Idiopathic Pulmonary Fibrosis
📧 Sign up to get email alerts when something new happens for Idiopathic Pulmonary Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-01-11Clinical Trial Update: Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of nintedanib given with sildenafil in patients with idiopathic pulmonary fibrosis and adv…
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 trial evaluating PRM-151 in idiopathic pulmonary fibrosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-11-13Clinical Trial Update: Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis [Phase 2, Phase 3]
Phase 2/3 clinical trial investigating vascular reactivity in idiopathic pulmonary fibrosis was terminated; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
Phase 2 clinical trial update for lebekizumab in idiopathic pulmonary fibrosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary Fibrosis [Phase 3]
Extension study assessing long-term safety of BIBF 1120 (nintedanib) in idiopathic pulmonary fibrosis after completion of prior trials.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-25Clinical Trial Update: A Validation and Dosimetry Study of GSK2634673F PET Ligand [Phase 1]
Phase 1 study evaluating the GSK2634673F PET ligand for validation and dosimetry in idiopathic pulmonary fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-06-13Clinical Trial Update: Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF) [Phase 4]
Phase 4 safety and tolerability trial evaluating the combination of pirfenidone and nintedanib in idiopathic pulmonary fibrosis. The study h…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients [Phase 1]
Phase 1 trial update evaluating inhaled therapy for idiopathic pulmonary fibrosis has completed, sponsored by GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: Study of Autologous Mesenchymal Stem Cells to Treat Idiopathic Pulmonary Fibrosis [Phase 1]
A Phase 1 trial evaluated autologous mesenchymal stem cells for idiopathic pulmonary fibrosis and has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-17Clinical Trial Update: Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF) [Phase 3]
Phase 3 trial results comparing nintedanib taken twice daily to placebo in idiopathic pulmonary fibrosis were posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-02-13Clinical Trial Update: Safety, Tolerability and PK of Nintedanib in Combination With Pirfenidone in IPF [Phase 4]
Phase 4 trial update assessing safety, tolerability, and pharmacokinetics of nintedanib in combination with pirfenidone in idiopathic pulmon…
-
CLINICAL_TRIALS trial_result · 2018-01-24Clinical Trial Update: Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations [Phase 1, Phase 2]
Phase 1/2 trial update evaluating the combination of plasma exchange, rituximab, and steroids for acute exacerbations of idiopathic pulmonar…
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and efficacy of allogeneic mesenchymal stem cells in rapidly progressive interstitial lung disease, comple…
-
CLINICAL_TRIALS trial_result · 2017-11-20Clinical Trial Update: Pilot Trial Of Omeprazole in Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]
A Phase 2 pilot trial evaluating omeprazole for idiopathic pulmonary fibrosis has completed. The study was sponsored by Newcastle-upon-Tyne …
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole [Phase 3]
Phase 3 trial evaluating cotrimoxazole for idiopathic pulmonary fibrosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis
A completed clinical trial update reports on the responsiveness and minimally important difference of the 4-meter gait speed test in idiopat…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: The Predictive Ability of 4MGS in IPF
The document reports on a completed clinical trial assessing how well four-meter gait speed (4MGS) predicts outcomes in idiopathic pulmonary…
-
CLINICAL_TRIALS trial_result · 2017-10-30Clinical Trial Update: A Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis [Phase 1]
This clinical trial update reports completion of a Phase 1 study evaluating the combination of oral vismodegib with pirfenidone in participa…
-
CLINICAL_TRIALS trial_result · 2017-07-26Clinical Trial Update: Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis
A completed clinical trial from the University of Michigan evaluating biomarker profiles in idiopathic pulmonary fibrosis.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis [Phase 2]
Phase 2 clinical trial update evaluating inhaled carbon monoxide as a treatment for idiopathic pulmonary fibrosis, with the study completed …
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide [Phase 3]
Phase 3 trial evaluating thalidomide for chronic cough in idiopathic pulmonary fibrosis completed, with results posted in May 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary Fibrosis [Phase 2]
A Phase 2 randomized dose-ranging study evaluated the efficacy of tralokinumab in adults with idiopathic pulmonary fibrosis; the trial was t…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Herpesvirus in Idiopathic Pulmonary Fibrosis
This clinical trial update indicates that a study examining herpesvirus involvement in idiopathic pulmonary fibrosis has completed. The snip…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients [Phase 1]
First-in-human Phase 1 study of GSK3008348 in healthy volunteers and idiopathic pulmonary fibrosis patients has been completed.
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
The study provides long-term safety data for pirfenidone (Esbriet) in patients with idiopathic pulmonary fibrosis, reporting completed safet…